HLA-DQA1, major histocompatibility complex, class II, DQ alpha 1, 3117
N. diseases: 427; N. variants: 101
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 6 | 32633427 | intron variant | C/G | snv | 5.2E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32629564 | intron variant | G/A | snv | 4.6E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32628470 | intron variant | G/T | snv | 5.0E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32632691 | intron variant | G/A | snv | 5.9E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32633277 | intron variant | C/A;G | snv | 5.0E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32638205 | intron variant | -/A;G | ins |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.120 | 6 | 32652506 | intergenic variant | C/T | snv | 0.49 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32637642 | intron variant | -/T | ins |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 6 | 32628532 | intron variant | C/T | snv | 0.76 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32628698 | intron variant | C/A | snv | 0.27 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.701 | 0.480 | 6 | 32638107 | intron variant | C/T | snv | 3.3E-03 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 6 | 32639087 | 3 prime UTR variant | T/C | snv | 0.16 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32639091 | 3 prime UTR variant | T/C | snv | 0.17 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32639165 | 3 prime UTR variant | G/A | snv | 0.25 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32639511 | 3 prime UTR variant | G/A | snv | 6.0E-03 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32640258 | intron variant | T/C | snv | 2.5E-03 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32640331 | intron variant | C/T | snv | 1.4E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32640474 | intron variant | C/G | snv | 8.7E-03 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32640640 | intron variant | G/A | snv |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 6 | 32640696 | intron variant | G/A | snv |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 6 | 32640706 | intron variant | T/C | snv |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 6 | 32640760 | intron variant | A/C | snv | 0.11 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32640930 | intron variant | T/C | snv | 0.18 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32641032 | intron variant | T/C | snv | 6.9E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32641679 | intron variant | C/T | snv | 4.6E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 |